Your email and its content will be used to provide you an answerto your message. You have the possibility to access, to modify, to rectify and to suppress any personal data concerning you.
To exercise this right, please click here.
Ipsen at a glance
The group in 2014
31 August 2015 - Paris (France)
Ipsen announces publication in The Lancet Neurology of the results of the phase III randomized study (NCT01313299) showing efficacy and…